ACOG Practice Bulletin No. 212: Pregnancy and Heart Disease

Unknown author(s)

Obstetrics and Gynecology · 2019 · 408 citations · 118 references

Concepts

TL;DR

Maternal heart disease is the leading cause of death among pregnant and postpartum women in the U.S., accounting for 26.5 % of pregnancy‑related deaths, with higher morbidity and mortality in nonwhite and low‑income women due to gaps in assessment, care, and symptom recognition. The document aims to describe the prevalence and impact of heart disease in pregnancy, provide guidance for early risk‑factor identification and modification, outline common cardiovascular disorders, recommend care for affected women, and present a comprehensive interpregnancy care plan. It achieves this by detailing prevalence and effects, offering guidance on early risk‑factor identification and modification, outlining common disorders, describing care recommendations, and presenting a comprehensive interpregnancy care plan.

Abstract

Maternal heart disease has emerged as a major threat to safe motherhood and women's long-term cardiovascular health. In the United States, disease and dysfunction of the heart and vascular system as "cardiovascular disease" is now the leading cause of death in pregnant women and women in the postpartum period () accounting for 4.23 deaths per 100,000 live births, a rate almost twice that of the United Kingdom (). The most recent data indicate that cardiovascular diseases constitute 26.5% of U.S. pregnancy-related deaths (). Of further concern are the disparities in cardiovascular disease outcomes, with higher rates of morbidity and mortality among nonwhite and lower-income women. Contributing factors include barriers to prepregnancy cardiovascular disease assessment, missed opportunities to identify cardiovascular disease risk factors during prenatal care, gaps in high-risk intrapartum care, and delays in recognition of cardiovascular disease symptoms during the puerperium. The purpose of this document is to 1) describe the prevalence and effect of heart disease among pregnant and postpartum women; 2) provide guidance for early antepartum and postpartum risk factor identification and modification; 3) outline common cardiovascular disorders that cause morbidity and mortality during pregnancy and the puerperium; 4) describe recommendations for care for pregnant and postpartum women with preexisting or new-onset acquired heart disease; and 5) present a comprehensive interpregnancy care plan for women with heart disease.

References

118